<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-TC0SV6ZS</identifier><date>2005</date><creator>Avancini, Nives</creator><creator>Godina-Kariž, Stanka</creator><creator>Kariž, Stojan</creator><relation>documents/doc/T/URN_NBN_SI_doc-TC0SV6ZS_001.htm</relation><relation>documents/doc/T/URN_NBN_SI_doc-TC0SV6ZS_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TC0SV6ZS_001.txt</relation><format format_type="issue">10</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 655-656</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">20411865</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TC0SV6ZS</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="eng">Adverse Effects</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="eng">Fundus Oculi</subject><subject language_type_id="eng">Hepatitis C</subject><subject language_type_id="slv">interferon</subject><subject language_type_id="eng">Interferon-alfa</subject><subject language_type_id="eng">Interferon-Alpha</subject><subject language_type_id="slv">izguba vida</subject><subject language_type_id="eng">Middle Age</subject><subject language_type_id="slv">Očesno ozadje</subject><subject language_type_id="slv">oftalmologija</subject><subject language_type_id="eng">Optic Neuropathy, Ischemic</subject><subject language_type_id="slv">Optična nevropatija ishemična</subject><subject language_type_id="slv">Srednja leta</subject><subject language_type_id="eng">Therapeutic Use</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">vid</subject><subject language_type_id="slv">zdravljenje</subject><title>Anterior ischemic optic neuropathy secondary to interferon alpha</title><title>Anteriorna ishemična optična nevropatija kot posledica zdravljenja z interferonom alfa</title></Record>